Ziprasidone mesylate - the first antipsychotic drug to be evaluated...

Ziprasidone mesylate is a new type of atypical broad-spectrum antipsychotic drug for the treatment of schizophrenia. Ziprasidone is a 5-hydroxytryptamine and dopamine receptor antagonist, especially...

See More

Ocumension‘s Anti-Allergy Eye Drug Approved for Marketing in China...

According to the official website of NMPA, Cetirizine Hydrochloride Eye Drops from Suzhou Ocumension Biotechnology Co. It is used for the treatment of itchy eyes associated with allergi...

See More

National Medical Products Administration : Multiple ways to promote the dev...

The National Information Office of China held a series of press conferences on the theme of "Promoting high-quality Development" on September 13.At the meeting, Huang Guo, deputy director o...

See More

Jioncare‘s marketing application for anti-flu drug TG-1000 capsules accepte...

Influenza, a contagious respiratory disease caused by influenza viruses, is currently one of the world‘s most serious public health challenges. Seasonal influenza occurs frequently each year. The ...

See More

New impurity | Canagliflozin impurity 8

The main impurity Canagliflozin Impurity 8, CAS number: 90-80-2 Molecular formula: C6H10O6 Molecular weight: 178.14 Chemical formula:：(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)...

See More

Pfizer‘s new anti-cancer drug axitinib declared for new indications in China...

On August 16, the official website of the Center For Drug Evaluation,NMPA announced that Pfizer‘s application for the listing of axitinib tablets for a new indication was accepted,。...

See More

Poly Pharm Receives U.S. Marketing Approval for New Specification of B...

Recently, FDA marketing authorization was granted for additional sizes of benzenesulfonium atracurium injection: 10mg/5ml and 200mg/20ml. Previously, Puli Pharma‘s benzenesulfonium atracurium ...

See More

Iohexol--drugs for medical imaging diagnosis...

Therefore, research on iohexol impurities pharmaceutical quality control is very critical, most of the current production and quality control of iohexol is based on the European Pharmacopoeia metho...

See More

Simelglutide Adds New Indication

Semaglutide is a long-acting glucagon-like peptide-1 receptor agonist (GLP-1RA), which has been approved for the treatment of type 2 diabetes mellitus and obesity in several countries and region...

See More

Baricitinib —— the solution to the problem of hair loss....

Jerry Shapiro said in WCD 2023 Oral Presentation. that for patients with a shorter course of alopecia areata, regardless of severity, the proportion of patients who get a clinical response aft...

See More

Drug Impurity ——glycoconjugate

Sugar compounds in drug impurity pairs include various types such as monosaccharides, oligosaccharides and polysaccharides. These sugar compounds may be present in different forms in drugs and thei...

See More

Tenofovir: full impurity supply

In terms of the human limits of impurities, the International Pharmacopoeia (WHO 11th edition) for tenofovir stipulates the following limits: the area of any peak due to tenofovir monoester (imp...

See More

New compound antibiotic - Avibactam

Avibactam is a novel β-lactamase inhibitor used in combination with ceftazidime for the treatment of serious infections caused by drug-resistant gram-negative bacteria. Current research on avibacta...

See More

Heat anti-Parkinson’s Disease——Carbidopa and LevodopaCR Tablets the f...

Recently,China Drug Administration (CDA)publicised the SJZ NO.4 Pharmaceutical approval certificate delivery information, CarbidopaandLevodopaCRTablets approved for listing, deemed t...

See More

Statin "Top Stream" is Coming - Rosuvastatin Impurities Supply...

The impurity study in its synthesis and quality control is an important part to ensure the safety and efficacy of the drug. Domestic and foreign pharmacopoeias have recorded the impurities of Rosuv...

See More

Beda Pharmaceuticals‘ CFT8919 Capsule Clinical Trial Application Acce...

On 9 July, Beda Pharmaceuticals and C4 Therapeutics, Inc. (C4T) received the Notice of Acceptance (Acceptance No. CXHL2400676 and CXHL2400677) from the State Drug Administratio...

See More

New Alzheimer‘s drug gets FDA approval for marketing...

The U.S. Food and Drug Administration (FDA) approved Kisunla™ (donanemab-azbt, 350 mg/20 mL once-monthly injection for IV infusion), Eli Lilly and Company‘s Alzheimer‘s treatment f...

See More

Finerenon,a new diabetic nephropathy drug...

Finerenone has been on the market for a short period of time, and with the accumulation of clinical experience and research evidence, it is expected to bring more benefits to diabetic nephropathy pat...

See More

Technical Guidelines for Clinical Trials of Drugs for Chronic Hepatitis D...

Technical Guidelines for Clinical Trials of Drugs for Chronic Hepatitis D Virus Infection

See More

Omadacycline: impurity studies of a new tetracycline antibiotic...

Omadacycline advantageous pathogens wide, can be used for a variety of identified pathogens caused by infections, in addition to the pharmacological mechanism of the study, in the quality control, th...

See More